GasthuisZusters Antwerpen

Wilrijk, Antwerpen 2610

0 studies enrolling now · 3 studies all time

What they study most

Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Neoplasm Metastasis, Relapsed and/or Refractory Multiple Myeloma, Urinary Bladder Neoplasm

Studies at this site

• A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer — Completed
• A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma — Completed
• Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer — Completed